*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Immunomodulators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global immunomodulators market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

Immunomodulators are a group of drugs used to modify an immune response against infectious diseases, immunodeficiency, and alterations in antibody transfer. These drugs generally include monoclonal antibodies, cytokines, levamisole, and Bacillus Calmette-Guerin (BCG). They are widely used to treat cancer, asthma, tumors, hereditary angioedema, and autoimmune disorders like pemphigus, lupus, allergies, and rheumatoid arthritis. Nowadays, several healthcare providers are recommending immunomodulators with other agents, such as biologics, for managing inflammatory bowel disease (IBD).

Immunomodulators Market Trends:

The unhealthy lifestyles of individuals on account of rapid urbanization, inflating income levels, and the increasing consumption of processed food products has led to a significant rise in the prevalence of chronic diseases worldwide. This is further escalating the need for organ transplantation, which is positively influencing the demand for topical immunomodulators as a promising therapeutic agent in organ transplant recipients. Moreover, the rising aging population and the growing number of accidents are also increasing the risk of organ failure. Consequently, several governing and non-governing authorities are encouraging organ donation, which, in turn, is boosting the sales of topical immunomodulators worldwide. Apart from this, the increasing prevalence of IBD and autoimmune disorders is bolstering the market growth. Immunomodulators are also utilized in combination therapy to decrease the long-term need for steroids and prevent recurring flares and treat diseases that do not respond to antibiotics. Furthermore, several immunomodulators, including Fluvoxamine, Tocilizumab, and Baricitinib with Remdesivir, are finding application for treating hospitalized patients with coronavirus disease (COVID-19). Besides this, several product candidates are currently in late-stage clinical trials. The development of these products is anticipated to expand the applications of immunomodulators for treating various life-threatening diseases.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunomodulators market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product and application.

Breakup by Product:

  • Immunosuppressants
    • Antibodies
    • Calcineurin Inhibitors
    • Glucocorticoids
    • Antimetabolites
    • Others
  • Immunostimulants
    • Vaccines
    • Antibodies
    • Others
       

Breakup by Application:

  • Oncology
  • Respiratory
  • HIV
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Product, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG and Pfizer Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global immunomodulators market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global immunomodulators market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunomodulators market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Immunomodulators Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Immunosuppressants
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Antibodies
           6.1.2.2 Calcineurin Inhibitors
           6.1.2.3 Glucocorticoids
           6.1.2.4 Antimetabolites
           6.1.2.5 Others
        6.1.3 Market Forecast
    6.2    Immunostimulants
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Vaccines
           6.2.2.2 Antibodies
           6.2.2.3 Others
        6.2.3 Market Forecast
7    Market Breakup by Application
    7.1    Oncology
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Respiratory
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    HIV
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Amgen Inc.
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Biogen Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    Bristol-Myers Squibb Company
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Eli Lilly and Company
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    F. Hoffmann-La Roche AG
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 SWOT Analysis
        13.3.6    Johnson & Johnson
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
           13.3.6.4 SWOT Analysis
        13.3.7    Merck & Co. Inc.
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
           13.3.7.4 SWOT Analysis
        13.3.8    Novartis AG
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Pfizer Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis

List of Figures

Figure 1: Global: Immunomodulators Market: Major Drivers and Challenges
Figure 2: Global: Immunomodulators Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Immunomodulators Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Immunomodulators Market: Breakup by Product (in %), 2020
Figure 5: Global: Immunomodulators Market: Breakup by Application (in %), 2020
Figure 6: Global: Immunomodulators Market: Breakup by Region (in %), 2020
Figure 7: Global: Immunomodulators (Immunosuppressants) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: Global: Immunomodulators (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Immunomodulators (Immunostimulants) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Immunomodulators (Immunostimulants) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Immunomodulators (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Immunomodulators (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Immunomodulators (Respiratory) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Immunomodulators (Respiratory) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Immunomodulators (HIV) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Immunomodulators (HIV) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Immunomodulators (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Immunomodulators (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: North America: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: North America: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: United States: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: United States: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Canada: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Canada: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Asia-Pacific: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Asia-Pacific: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: China: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: China: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Japan: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Japan: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: India: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: India: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: South Korea: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: South Korea: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Australia: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Australia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Indonesia: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Indonesia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Others: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Europe: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Europe: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Germany: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Germany: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: France: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: France: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: United Kingdom: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: United Kingdom: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Italy: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Italy: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Spain: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Spain: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Russia: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Russia: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Others: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Latin America: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Latin America: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Brazil: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Brazil: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Mexico: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Mexico: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Others: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Others: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Middle East and Africa: Immunomodulators Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Middle East and Africa: Immunomodulators Market: Breakup by Country (in %), 2020
Figure 67: Middle East and Africa: Immunomodulators Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Global: Immunomodulators Industry: SWOT Analysis
Figure 69: Global: Immunomodulators Industry: Value Chain Analysis
Figure 70: Global: Immunomodulators Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Immunomodulators Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Immunomodulators Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Immunomodulators Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: Immunomodulators Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: Immunomodulators Market: Competitive Structure
Table 6: Global: Immunomodulators Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links